QIAGEN at AMP 2024

Meet QIAGEN at the 2024 Association for Molecular Pathology (AMP) Annual Meeting This year at the 2024 Association for Molecular Pathology (AMP) Annual Meeting, QIAGEN will showcase our barrier-breaking Sample to Insight Oncology solution. Combining targeted DNA and multimodal pan-cancer panels, one of the fastest and cheapest secondary analysis solutions in the market, and industry-leading variant […]

Investigating genomic variants using QIAGEN CLC Genomics Workbench, QCI Interpret-Translational (QCII-T), and Ingenuity Pathway Analysis (IPA)

Virtual - Americas - EST

Discovery of new genes implicated in hereditary diseases or cancer progression is challenging and advancing rapidly with an increase in the amount of cohort data to analyze from next generation sequencing (NGS) data to associations between gene variants and diseases, and finally to biological mechanisms of these gene variants. Combining QIAGEN CLC Genomics Workbench, QCII-T, […]